A study on the relationship between remnant stomach volume and postoperative QOL

A study on the relationship between remnant stomach volume and postoperative QOL - A study on the relationship between remnant stomach volume and postoperative QOL

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000038517

Enrollment

300

Registered

2019-11-08

Start date

2019-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Intravenously infuse butylscopolamine 1A (10 mg). Patients with glaucoma, benign prostatic hyperplasia use glucagon (not for patients with diabetes). After taking 6 g of foaming agent with 10 ml of w

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Gastrectomy for gastric cancer since 2010 No recurrence for more than 1 year after surgery Has not developed a malignant tumor within the past 5 years (excluding intramucosal cancer) Consent is obtained in writing Gastric resection is scheduled at this hospital

Exclusion criteria

Exclusion criteria: Taking postoperative adjuvant therapy or taking medication for side effects of postoperative adjuvant therapy Comorbidities of poor control (including insulin use and oral steroids) Cases judged by the attending physician as ineligible

Design outcomes

Primary

Measure	Time frame
The relationship of PGSAS-37 and remnant stomach volume	—

Secondary

Measure	Time frame
The relationship of body composition change and remnant stomach volume	—

Countries

Japan

Contacts

Public ContactRyo Tanaka

Osaka Medical College Department of General and Gastroenterological Surgery

sur148@osaka-med.ac.jp072-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026